Advancements in Radiopharmaceuticals and Digital Detectors: The Engine Powering Positron Emission Tomography Market Research and Innovation
  The foundation of the Positron Emission Tomography (PET) market is deeply rooted in continuous technological and clinical research, pushing the boundaries of molecular imaging. The development of novel radiotracers represents the forefront of this effort, moving beyond the ubiquitous 18F-FDG to agents like 68Ga-PSMA and 18F-Fluciclovine, which target specific biomarkers for personalized...
0 Comments 0 Shares 20 Views 0 Reviews